Therapeutic efficacy of combined PEGylated liposomal doxorubicin and radiofrequency ablation: Comparing single and combined therapy in young and old mice-Reference-Cited by-同舟云学术

Therapeutic efficacy of combined PEGylated liposomal doxorubicin and radiofrequency ablation: Comparing single and combined therapy in young and old mice

Published:2017-07 Issue: Volume:257 Page:2-9
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Andriyanov Alexander V.,Portnoy Emma,Koren Erez,Inesa Semenenko,Eyal Sara,Goldberg S. Nahum,Barenholz Yechezkel

Funder

Barenholz Fund

Israel Science Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Geriatric oncology: an overview of progresses and challenges;Extermann;Cancer Res. Treat.,2010

2. Cancer in the elderly;Berger;Trans. Am. Clin. Climatol. Assoc.,2006

3. Pharmacotherapy considerations in elderly adults;Wooten;South. Med. J.,2012

4. Aging, immunity and cancer;Hakim;Curr. Opin. Immunol.,2004

5. The endocrine system and ageing;Chahal;J. Pathol.,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions;ACS Nano;2024-05-20

2. AN UPDATED REVIEW OF STEALTH LIPOSOMES AND ITS ABILITY TO EVADE THE IMMUNE SYSTEM: A NEW FRONTIER IN CANCER CHEMOTHERAPY;International Journal of Applied Pharmaceutics;2024-05-07

3. The Emerging Landscape for Combating Resistance Associated with Energy‐Based Therapies via Nanomedicine;Advanced Materials;2023-11-28

4. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy;Journal of Controlled Release;2023-08

5. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery;BioDrugs;2023-04-24